logo

Breaking News

Share

Shares of risk and compliance solutions company Donnelley Financial Solutions, Inc. (DFIN) are rising more than 17% Wednesday morning on better-than-expected second-quarter results.

Shares of The Walt Disney Company (DIS) are climbing more than 9% Wednesday morning at $128.50. It has traded in the range of $79.07- $153.41 in the past 52 weeks.

Shares of Horizon Therapeutics Public Ltd. Co. (HZNP) are gaining over 15% on Wednesday morning after the company's second-quarter results trumped Wall Street view, driven by "tremendous" response for its drug Tepezza, a treatment for Thyroid Eye Disease. The company also lifted its full-year revenue...

Shares of Square Inc. (SQ) are rising more than 14 percent or $19.75 in Wednesday's morning trade at $156.58, after earlier touching a new 52-week high of $158.43 as the payment processor reported increase in revenue for the second quarter. Tuesday, Square reported net loss for the second quarter...

Shares of technology company providing comprehensive testing solutions through its scalable technology platform Fulgent Genetics, Inc. (FLGT) are rising more than 20% Wednesday morning on upbeat second-quarter results.

Shares of conversational commerce and AI software developer LivePerson, Inc. (LPSN) are surging more than 20% Wednesday morning after the company raised its full-year revenue outlook, better than the Street view.

Shares of New Relic, Inc. (NEWR) are losing almost 24 percent or $17.56 in Wednesday's morning trade at $55.94 after the software-as-a-service company reported a wider net loss for the first quarter. Tuesday, New Relic reported first-quarter attributable net loss of $29.76 million or $0.50 per share,...

Shares of DarioHealth Corp. (DRIO) are gaining over 20% on Wednesday morning, continuing its upward momentum from last Friday. On July 31, the company revealed that it raised over $28 million to fund growth of their digital therapeutics B2B market share. DRIO is currently trading at $16.79, up $2.95...

Amazon.com, Inc. (AMZN) said it plans to launch a new, state-of-the-art Amazon fulfillment center in Temple Terrace, Florida. The new fulfillment center, which is anticipated to launch in 2021, will create 750 full-time jobs. The operations facility will span more than 600,000 square feet on the ground...

Walmart Inc. (WMT) announced the launch of Walmart Drive-in, which will transform Walmart parking lots into outdoor cinemas from August 14 through October 21 with 320 showings of hit movies. The Walmart Drive-in ensures a contact-free experience where audiences can watch popular films safely from their...

Boehringer Ingelheim and Eli Lilly and Co. (LLY) said that Empagliflozin met primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in the EMPEROR-Reduced Phase III trial in adults with and without diabetes. The study results demonstrated superiority with empagliflozin...

The Wendy's Company (WEN) reported second quarter adjusted earnings per share of $0.12 compared to $0.18, prior year. On average, 28 analysts polled by Thomson Reuters expected the company to report profit per share of $0.11, for the quarter. Analysts' estimates typically exclude special items. Second...

Pfizer Inc. (PFE) announced Monday that the positive results from Phase 3 CROWN study of LORBRENA (lorlatinib) in people with previously untreated advanced anaplastic lymphoma kinase or ALK-positive non-small cell lung cancer or NSCLC. The trial met its primary endpoint by demonstrating significantly...

Thermo Fisher Scientific Inc. (TMO) said Wednesday it has unveiled a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day, to meet increasing global demand for COVID-19 testing. According to the company, the high-throughput system enables laboratories...

Johnson & Johnson (JNJ) said Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval....

Follow RTT